Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Screening vaccine candidate strains against Streptococcus agalactiae of tilapia based on PFGE genotype.

Vaccine - 14 Sept 2012

Chen Ming, Wang Rui, Li Li-Ping, Liang Wan-Wen, Li Jian, Huang Yan, Lei Ai-Ying, Huang Wei-Yi, Gan Xi

Abstract excerpt

The immunogenicity identification of epidemic strain is important for the development and application of vaccine. In this study, 85 Streptococcus agalactiae prevalent strains from the tilapia main cultured areas of China were distributed among 10 distinct PFGE genotypes (A-J). For each genotype,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bacterial Vaccines
Share to Cross Protection
Share to Electrophoresis, Gel, Pulsed-Field

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Fish Diseases

Share to Genotype

Share to Neonatal and Maternal Infections

Share to Streptococcus agalactiae

Share to Tilapia

Source

Identifiers

PMID: 22867719
DOI: 10.1016/j.vaccine.2012.07.044

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-22867719-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Screening vaccine candidate strains against Streptococcus agalactiae of tilapia based on PFGE genotype.PMID 22867719Read ↗

Rare serotype occurrence and PFGE genotypic diversity of Streptococcus agalactiae isolated from tilapia in China.Semantic proximity Read ↗

Molecular typing of Streptococcus agalactiae isolates of serotype Ia from tilapia in southern ChinaSemantic proximity Read ↗

Molecular characterization and pathogenicity of Streptococcus agalactiae serotypes Ia ST7 and III ST283 isolated from cultured red hybrid tilapia in MalaysiaSemantic proximity Read ↗

Potential of naturally attenuated Streptococcus agalactiae as a live vaccine in Nile tilapia (Oreochromis niloticus)Semantic proximity Read ↗

CRISPR-Cas9-Mediated Construction of a Streptococcus agalactiae Vaccine for Tilapia and Evaluation of Its Protective EfficacySemantic proximity Read ↗

Molecular characterization of Streptococcus agalactiae in diseased farmed tilapia in ChinaSemantic proximity Read ↗

Analysis of the efficacy of two molecular adjuvants,flagellin and IFN-γ,on the immune response against Streptococcus agalactiae in Nile tilapia (Oreochromis niloticus)Semantic proximity Read ↗

Inapparent Streptococcus agalactiae infection in adult/commercial tilapiaSemantic proximity Read ↗

PCR detection and PFGE genotype analyses of streptococcal clinical isolates from tilapia in ChinaSemantic proximity Read ↗

Complete Genome Sequence of Streptococcus agalactiae GD201008-001, Isolated in China from Tilapia with MeningoencephalitisSemantic proximity Read ↗

Capsular polysaccharide of Streptococcus agalactiae is an essential virulence factor for infection in Nile tilapia (Oreochromis niloticus Linn.)Semantic proximity Read ↗

Identification and molecular typing of Streptococcus agalactiae isolated from pond-cultured tilapia in ChinaSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.